T Cell Targeting by Anthrax Toxins: Two Faces of the Same Coin

Author： Paccani Silvia Rossi Baldari Cosima T.

Publisher： MDPI

E-ISSN： 2072-6651|3|6|660-671

ISSN： 2072-6651

Source： Toxins, Vol.3, Iss.6, 2011-06, pp. : 660-671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Bacillus anthracis, similar to other bacterial pathogens, has evolved effective immune evasion strategies to prolong its survival in the host, thus ensuring the unchecked spread of the infection. This function is subserved by lethal (LT) and edema (ET) toxins, two exotoxins produced by vegetative anthrax bacilli following germination of the spores. The structure of these toxins and the mechanism of cell intoxication are topics covered by other reviews in this issue. Here we shall discuss how B. anthracis uses LT and ET to suppress the immune defenses of the host, focusing on T lymphocytes, the key players in adaptive immunity. We shall also summarize recent findings showing that, depending on its concentration, ET has the ability not only to suppress T cell activation but also to promote the polarization of CD4⁺ T cells to the Th2 and Th17 subsets, highlighting the potential use of this toxin as an immunomodulator.